|
End-of-day quote
Shanghai S.E.
13/08/2026
|
5-day change | 1st Jan Change | ||
| 5.090 CNY | +0.99% |
|
+2.83% | -0.59% |
| 07-29 | Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring | MT |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| Market Cap | 25.38B 3.76B 3.26B 3.06B 2.79B 5.25B 359B 5.33B 36B 14.06B 180B 14.13B 13.82B 600B | P/E 2026 * |
11x | P/E 2027 * | 10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.06B 3.12B 2.71B 2.54B 2.31B 4.35B 298B 4.42B 29.88B 11.66B 149B 11.72B 11.47B 498B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.1% | Yield 2027 * | 4.38% |
| 1 day | +0.99% | ||
| 1 week | +2.83% | ||
| Current month | -1.17% | ||
| 1 month | +0.59% | ||
| 3 months | +0.39% | ||
| 6 months | -1.17% | ||
| Current year | -0.59% |
| 1 week | 4.93 |  | 5.17 |
| 1 month | 4.87 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Hua Gong
CEO | Chief Executive Officer | 48 | 14/10/2024 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 14/11/2023 |
Wei He
CEO | Chief Executive Officer | 40 | 22/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gu Liang Tang
BRD | Director/Board Member | 64 | 04/11/2020 |
Bao Lin Liu
CHM | Chairman | 73 | 31/10/2008 |
Zhao Nian Liu
BRD | Director/Board Member | 66 | 15/11/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/06/24 | Buy | Chief Executive Officer | 60,494 | 0.0015% | ||
| 07/06/24 | Buy | 3,025 | 0.0001% | |||
| 07/06/24 | Buy | Director | 1,210 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.99% | +2.83% | -5.57% | -4.04% | 3.76B | |
| +0.67% | -0.65% | +28.21% | +97.24% | 99.88B | |
| +0.27% | -1.79% | +54.56% | +149.68% | 53.78B | |
| 0.00% | 0.00% | +4.20% | +270.19% | 24.2B | |
| +1.33% | +2.13% | -11.64% | -12.97% | 8.32B | |
| +0.20% | +6.25% | -31.86% | -25.03% | 7.69B | |
| -0.24% | -1.53% | -13.83% | -21.78% | 6.66B | |
| +0.64% | +2.02% | +8.99% | +19.63% | 6.23B | |
| +0.28% | -1.46% | -6.20% | +19.29% | 4.96B | |
| +0.39% | -0.19% | +9.70% | +14.87% | 3.62B | |
| Average | +0.44% | -0.41% | +3.66% | +50.71% | 21.91B | |
| Weighted average by Cap. | +0.46% | -1.45% | +24.92% | +110.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.18B 21.82B 20.46B 18.65B 35.1B 2,403B 35.66B 241B 94.04B 1,203B 94.52B 92.47B 4,012B | 178B 26.45B 22.93B 21.49B 19.6B 36.87B 2,524B 37.46B 253B 98.79B 1,264B 99.29B 97.14B 4,215B |
| Net income | 2.33B 345M 299M 281M 256M 481M 32.96B 489M 3.3B 1.29B 16.5B 1.3B 1.27B 55.03B | 2.52B 373M 324M 303M 277M 520M 35.62B 529M 3.57B 1.39B 17.83B 1.4B 1.37B 59.48B |
| Net Debt | -4.32B -641M -555M -521M -475M -893M -61.14B -907M -6.13B -2.39B -30.61B -2.41B -2.35B -102B | -5.04B -748M -648M -608M -554M -1.04B -71.36B -1.06B -7.15B -2.79B -35.72B -2.81B -2.75B -119B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | CN¥5.060 | -0.59% | 26,936,680 |
| 13/08/26 | CN¥5.090 | +0.99% | 45,553,731 |
| 12/08/26 | CN¥5.040 | -0.59% | 43,655,619 |
| 11/08/26 | CN¥5.070 | +0.40% | 43,661,675 |
| 10/08/26 | CN¥5.050 | +1.20% | 45,445,440 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
